Call for Abstract
International Conference on Biomarkers and Cancer Targets, will be organized around the theme “A Lifesaving mission to end cancer forever”
Cancer Targets 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cancer Targets 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Cancer is a gathering of sicknesses including irregular cell development with the possibility to attack or spread to different parts of the body. These stand out from benevolent tumours, which don't spread to different parts of the body. Possible signs and side effects incorporate a bump, strange dying, delayed hack, unexplained weight reduction, and an adjustment in gut movements. Tobacco use is the cause of about 22% of cancer deaths. Another 10% are due to obesity, poor diet, lack of physical activity, and excessive drinking of alcohol. Other factors include certain infections, exposure to ionizing radiation and environmental pollutants. In the developing world, 15% of cancers are due to infections such as Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus infection, Epstein–Barr virus and human immunodeficiency virus.
- Track 1-1Lung cancer
- Track 1-2Prostate cancer
- Track 1-3Colorectal cancer
Cancer biomarkers can be DNA, mRNA, proteins, metabolites, or processes such as apoptosis, angiogenesis or proliferation. The markers are produced either by the tumor itself or by other tissues, in response to the presence of cancer or other associated conditions, such as inflammation. Such biomarkers can be found in a variety of fluids, tissues and cell lines. "A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.
- Track 2-1Prognostic biomarker
- Track 2-2Stratification (predictive) biomarker
- Track 2-3Diagnostic (screening) biomarker
Biomarkers play a key role in the diagnosis and management of patients with cancer, and are important for fulfilling the promise of precision medicine in oncology. However, although numerous biomarkers have been shown to have clinical validity, many have not undergone rigorous testing to demonstrate clinical utility so that they can be appropriately incorporated into clinical care. This review article highlights the characteristics of a good biomarker and the steps required to demonstrate clinical utility, and gives examples of both successful established biomarkers and promising new tissue-based and circulating biomarkers on the horizon.
- Track 3-1Circulating tumour cell
- Track 3-2Circulating tumour DNA
- Track 3-3Clinical utility
A Biomarker is the organic particle found in blood, other body liquids, or tissues that is an indication of a typical or anomalous process, or of a condition or disease. A biomarker might be utilized to perceive how well the body reacts to a treatment for a malady or condition. Likewise called molecular marker and mark particle. Cancer biomarkers are arranged by their diverse capacities: Biomarkers that Trigger Cells to Grow and Multiply Abnormally, Biomarkers That Support a Treatment's Cellular or Molecular Action, Biomarkers That Disrupt a Treatment's Cellular or Molecular Action, Detecting and Measuring Biomarkers to Develop a Personalized Anticancer Treatment Plan.
- Track 4-1Genomic Biomarker
- Track 4-2Transcriptomic Biomarker
- Track 4-3Metabolomics Biomarker
- Track 4-4Drug activity markers
- Track 4-5Imaging Biomarker
Surgical oncology is the branch of surgery applied to oncology; it focuses on the surgical management of tumours, especially cancerous tumours. Surgery is used to diagnose, stage and treat cancer, and certain cancer-related symptoms. Surgeons have performed thousands of procedures and will discuss appropriate surgical options that meet your individual needs. Childhood cancers are different from adult cancers. The Advanced Surgical Recovery Program (ASURE) is designed to help patients recover from surgery more quickly and with fewer complications. Lymphadenectomy. ASURE is intended to improve surgical outcomes and enhance the patient experience before, during and after surgery, while also reducing patients’ overall hospital stay.
- Track 5-1Pancreaticoduodenectomy
- Track 5-2Thyroidectomy
- Track 5-3Appendix surgery
Childhood growth (otherwise called pediatric malignancy) is disease in a kid. Pediatric oncology is the branch of medication worried about the determination and treatment of disease in kids. A pediatric oncologist spends significant time in research and treatment for growths that create in babies, little children, youngsters, youths and adolescents. This is one reason why there is a requirement for pediatric oncologists who are prepared in treating the two youngsters and growth. Numerous pediatric oncologists additionally represent considerable authority in hematology, which is the investigation and treatment of sicknesses identified with the blood. These specialists are in some cases alluded to as pediatric oncologists/hematologists
- Track 6-1Neuroblastoma
- Track 6-2Wilms tumour
- Track 6-3Pediatric Neuro oncologist
- Track 6-4Hepatoblastoma and hepatocellular carcinoma
A haematologist-oncologist is a physician who specializes in the diagnosis, treatment and/or prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. This physician is trained in haematology — the study of blood — and oncology — the study of cancer. Hematologist-oncologists do not usually treat operable cancers such as prostate cancer, but specialize in treating blood cancers, such as Hodgkins and non-Hodgkins lymphomas, leukemias and multiple myelomas.
- Track 7-1Haemophilia
- Track 7-2Bone marrow disease
- Track 7-3Anticoagulation therapy
- Track 7-4Blood transfusion
A gynaecologist oncologist is a physician who specializes in diagnosing and treating cancers that are located on a woman’s reproductive organs The gynecologic oncologist serves as the captain of a woman’s gynecologic cancer care team. A gynecologic oncologist is a specialist in obstetrics and gynaecology who by virtue of education and training is prepared to provide consultation on and comprehensive management of patients with gynecologic cancer and whose present activity includes the practice of gynaecologic oncology in an institutional setting wherein all the effective forms of cancer therapy are available.
- Track 8-1Cervical Cancer
- Track 8-2Vaginal Cancer
- Track 8-3Diagnostic tests
- Track 8-4Ovarian cortex cryopreservation
- Track 8-5Vulvar cancers
An orthopaedic (orthopaedic) oncologist is a physician and surgeon who specialize in the diagnoses and treatment of primary benign and malignant tumors of the bones. The Division of Orthopaedic Oncology offers expert care to children and adults diagnosed with tumours and tumour-like conditions of the bone and soft tissue, including bone metastases, sarcomas, benign and cancerous tumors of the bone or soft tissue and pathologic fractures. Treatment of various forms of primary benign and malignant neoplasms of the bones and bony structures of the human body (any cancer which has originated from the bone, as opposed to cancers which originated from other organs and have secondarily spread, or metastasized, to the bones, which is much more common; these specialists deal mostly with primary bone tumors).
- Track 9-1Musculoskeletal Radiologists
- Track 9-2Malignant Bone Tumours
- Track 9-3Lobular carcinoma
- Track 9-4Chondrosarcoma
Breast cancer begins in the cells of the breast. A harmful tumour is a gathering of growth cells that can develop into and annihilate close-by tissue. It can likewise metastasize to different parts of the body. Cells in the breast some of the time change and never again develop or act ordinarily. These progressions may prompt non-malignant bosom conditions, for example, atypical hyperplasia and sores. They can likewise prompt non-carcinogenic tumours, for example, intraductal papillomas.
- Track 10-1Breast cancer screening
- Track 10-2Breast reconstruction
- Track 10-3Lobular carcinoma
- Track 10-4Abortion–breast cancer hypothesis
Neuro-oncology is the investigation of cerebrum and spinal string neoplasms, a significant number of which are (at any rate in the end) extremely perilous and hazardous (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and mind stem tumours are among the numerous cases of these).
- Track 11-1Neuro-oncologists
- Track 11-2Head and Neck Surgery
- Track 11-3Neuropathology Department
- Track 11-4Spectroscopic imaging
- Track 11-5Helical Multi Detector CT Scanners
Pathophysiology of cancer incorporates reason for the sickness, conclusion, how the infection creates, instrument and characteristic course of the illness. They additionally manage biochemical highlights, movement, and guess or result of the ailment. Pathology of tumours and other complex issue have experienced an ocean change after improvement of innovations like immunohistochemistry, stream cytometry, and sub-atomic biologic ways to deal with malignancy analysis.
- Track 12-1Genetic changes
- Track 12-2Genomic amplification
- Track 12-3Translocation
- Track 12-4Solid tumour parts
Cancer pharmacology incorporate investigations of the fundamental mechanism of signal transduction related with cell multiplication and apoptosis, the mechanism of activity of anti-neoplastic specialists, the outline and revelation of new medications, essential components of DNA repair and DNA harm resilience and the advancement of novel techniques for quality treatment.
- Track 13-1Human cancer cell lines
- Track 13-2Genetic manipulation of cancer
- Track 13-3Malignant transformation
- Track 13-4Cancer cell proliferation
Atomic Cancer Therapeutics will concentrate on fundamental research that has suggestions for growth therapeutics in the accompanying zones: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The diary gives a production discussion to these rising orders that is centered particularly around disease look into. Papers are stringently looked into and just those that report aftereffects of novel, opportune, and noteworthy research and meet exclusive expectations of logical legitimacy will be acknowledged for production.
- Track 14-1Molecular cancer Therapeutics
- Track 14-2 Neurotherapeutics
- Track 14-3Pharmacology and clinical Toxicology
- Track 14-4Therapeutics
- Track 14-5Biomolecules and Therapeutics
- Track 15-1Psorinum Therapy of Cancer
- Track 15-2Homeopathic drugs
- Track 15-3Homeopathic Cancer Research
- Track 15-4Beneficial clinical effects of Homeopathic drugs
- Track 15-5Anti-cancer Effects of Homeopathic Drugs
- Track 15-6Research Methodologies and Mechanism of Action
Cancer epigenetics is the investigation of epigenetic alterations to the DNA of malignancy cells that don't include an adjustment in the nucleotide arrangement. Epigenetic changes might be similarly as vital, or much more critical, than hereditary changes in a cell's change to malignancy. A variety of compounds are considered as epigenetic carcinogens such as arsenite, diethylstilbestrol, hexachlorobenzene and nickel compounds. They result in an increased incidence of tumors, but they do not show mutagen activity.
- Track 16-1DNA binding proteins
- Track 16-2Histone modification
- Track 16-3Genetic mutations
- Track 16-4Tumour suppressor gene
Cancer is to a great extent an inherited infection, as though destiny and the family quality pool alone direct your odds of becoming ill. A sound eating routine is fundamental to tumour anticipation, particularly a regimen concentrated on settling on nutritious decisions, favouring natural nourishment, eating with some restraint and preparing foods properly . It's about adjust, control and assortment. By eating the correct nourishment, expending a wide range of supplements and not devouring more than your body requires, you can help decrease your danger of malignancy and different illnesses.
- Track 17-1Control your weight
- Track 17-2Be more active
- Track 17-3Eat healthy foods
- Track 17-4Healthy Lifestyle
Proteomics advancements are utilized for early discovery and finding of diseases for the improvement of novel restorative operators. Distinguishing proof of biomarker and furthermore the investigation of protein articulation of the disease are examined through proteomics stages. These investigations have prompted the advancement of finding new medications and focused on therapeutics towards the tumour cells. Identification, anticipation, finding and treatment of breast malignancy is presently conceivable with the headways in the field of proteomics alongside the utilization of mass spectrometry. The disclosure of the protein designs has empowered scientists to recognize the disease and disease free-state related with breast disease has been revealed with the improvement of proteomics advancements. This revelation prompts customized treatment for the patients. Proteins communicated or found in the serum, plasma and the tumour cells utilizing the novel procedures give a superior perspective of the heterogeneity of the diseases.
- Track 18-1Genes and protein altered in cancer
- Track 18-2Protein expression of cancer genes
- Track 18-3Tumour biology
- Track 18-4Leukaemia and lymphoma
Cancer Molecular epidemiology is a branch of oncology and epidemiology that focuses on the contribution of potential environmental and genetic risk factors, identified at the molecular level, to the etiology, distribution and prevention of cancer within families and across populations. The goal of molecular epidemiology is to supplement and integrate existing methods. Molecular epidemiology of cancer studies molecular markers of distribution of malignant tumours in the population and their effects on individual risk of developing a disease. Molecular markers can be detected in tissues and biological liquids and characterize individual exposure to carcinogens, biological effect of the exposure, genetic susceptibility to the development of disease, and final result of carcinogenesis. Identification of specific somatic molecular and genetic changes, so-called fingerprints, is very important for the molecular characteristics of a tumour and confirmation of etiology.
- Track 19-1Disease surveillance
- Track 19-2Case series
- Track 19-3Case-control studies
- Track 19-4Prostate cancer screening
- Track 19-5Prostate-specific antigen
A prognostic factor is an element of the malignancy (like the extent of the tumour) or a normal for the individual (like their age) that may influence the result. A predictive factor can help foresee if a malignancy will react to a specific treatment. A few medications just work if atoms, (for example, proteins) are on growth cells or inside them. These are some essential prognostic elements identified with the tumour: The sort of disease, The subtype of malignancy in light of the sort of cells or tissue (histology), The extent of the tumour, How far and where the malignancy has spread, How quick the malignancy cells are developing. Important predictive elements incorporate a few sorts of tumour markers, biomarkers and changes to chromosomes (hereditary transformations).
- Track 20-1Human papillomavirus infection
- Track 20-2Adrenal Carcinoma Prognosis
- Track 20-3Lymphoma Prognosis
- Track 20-4Basal Cell Carcinoma Prognosis
- Track 20-5Mucoepidermoid Carcinoma Prognosis
There are various types of nurse care associated with cancer treatments. Authority medical attendants, ward medical care takers, Community medical care takers, Specialist palliative care medical attendants, Marie Curie Cancer Care Nurses. Authority attendants work primarily in doctor's facilities, however some give mind in the patient's home. They may have some expertise in a particular malignancy for instance bosom, lung, head and neck disease, or a specific treatment, for instance chemotherapy. Community attendants give an extensive variety of nursing care including helping patients when they leave clinic, taking out fastens, wiping wounds and giving out some prescription at home. Authority palliative care medical care takers have skill in overseeing torment and different manifestations, and can offer help for individuals with growth and their families. Marie Curie medical caretakers give hands on mind at home during that time or night, offering the carer a reprieve. They will have exceptional learning of palliative care.
- Track 21-1Anticipatory grieving
- Track 21-2Altered Nutrition: Less than Body Requirements
- Track 21-3Risk for Fluid Volume Deficit
- Track 21-4Risk for Infection
There are several methods of diagnosing cancer. With advances in technologies that understand cancers better, there is a rise of number of diagnostic tools that can help detect cancers. Once suspected, diagnosis is usually made by pathologists and oncopathologists and imaging radiologists. Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. Diagnostics plays an important role throughout your cancer treatment it includes Before treatment, During your treatment, After you complete treatment.
- Track 22-1Biopsy
- Track 22-2Sentinel node biopsy
- Track 22-3Endoscopy
- Track 22-4Blood tests
- Track 22-5Bone marrow aspiration
The expulsion of cells or tissues for examination by a pathologist. The pathologist may ponder the tissue under a magnifying lens or perform different tests on the cells or tissue. There are a wide range of sorts of biopsy techniques. The most widely recognized sorts include: (1) incisional biopsy, in which just an example of tissue is evacuated; (2) excisional biopsy, in which a whole irregularity or suspicious zone is expelled; and (3) needle biopsy, in which a specimen of tissue or liquid is expelled with a needle. At the point when a wide needle is utilized, the strategy is known as a center biopsy. At the point when a thin needle is utilized, the methodology is known as a fine-needle goal biopsy.
- Track 23-1Bone marrow aspiration and biopsy
- Track 23-2Endoscopic biopsy
- Track 23-3Needle biopsy
- Track 23-4Tumour Marker Tests
Magnetic resonance imaging (MRI) is a scanning procedure that uses strong magnets and radiofrequency pulses to generate signals from the body. These signals are detected by a radio antenna and processed by a computer to create images (or pictures) of the inside of your body. The MRI scanner is generally shaped like a large, covered box with a tunnel passing through it. A table, on which you lie, slides into the tunnel. Both ends of the scanner are open and will not close. The tunnel has lights in it and sometimes a mirror.
- Track 24-1Real-time MRI
- Track 24-2Interventional MRI
- Track 24-3Medical imaging
- Track 24-4NMR applications
- Track 24-5Diagnostic medicine
Tumour is one of the best wellbeing challenges, and a main source of death in each edge of the world. The worldwide market for Cancer drugs is anticipated to develop twice as quick as that of different pharmaceuticals throughout the following couple of years. Top organizations incorporate Janssen biotech, Takeda oncology, Boehringer ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, and Amgen. The growth business is the most ordinarily profitable business in the USA. It has been seen that, there are 1,665,540 new malignancy cases analysed and 585,720 growth passing in the US in the year 2014. $6 billion of citizen stores are spun through different government organizations for malignancy explore for the most part as the National Cancer Institute . The NCI states that the restorative expenses of disease mind are $125 billion, with the ascent of 39 percent to $173 billion by the up and coming year that is 2020. The most well-known maxim of the growth business is it utilizes an excessive number of individuals and delivers excessively pay to enable a cure to be found.
- Track 25-1Cancer drugs
- Track 25-2Novartis
- Track 25-3Johnson & Johnson
- Track 25-4Cancer research
- Track 25-5National Cancer Institute
The association between cancer prevalence and race, income, insurance, and education was estimated using the Medical Expenditure Panel Survey data from 1996-2007. The goal of this analysis was to provide some insight into how variations in race and socioeconomic factors influence the prevalence of cancer. This analysis was conducted for any cancer and for the four most common cancer sites i.e lung, colorectal, breast and prostate. Initially, the model was estimated using MEPS data from 2002-2007 to include body mass index, exercise and smoking behaviour as predictors in the model. This data is not available in the MEPS for the prior years. We compared the results of our model with and without these variables and concluded that they did not confound the associations between cancer prevalence and race, income, insurance, and education. Therefore, we dropped these variables from the analysis and were able to expand our data to include the years 1996-2001. This increased the number of persons with cancer in our analysis and was important for our analysis of the four most common cancer sites.
- Track 26-1Cancer-Causing Substances.
- Track 26-2Chronic Inflammation
- Track 26-3Immunosuppression
- Track 26-4Infectious agents
The financial costs of cancer are high for both the person with cancer and for society as a whole. The Agency for Healthcare research and Quality (AHRQ) estimates that the direct medical costs (total of all health care costs) for cancer in the US in 2014 were $87.8 billion.58% of this cost is for hospital outpatient or doctor office visits, 27% of this cost is for inpatient hospital stays. These estimates are based on a set of large-scale surveys of individuals and their medical providers called the Medical Expenditure Panel Survey (MEPS). One of the major costs of cancer is cancer treatment. But lack of health insurance and other barriers to health care prevent many Americans from getting optimal health care. According to the US Census Bureau, about 29 million people (9%) in the US were uninsured in 2015.The percentage of uninsured ranged from 3% in Massachusetts to 17% in Texas.
- Track 27-1Medical Expenditure Panel Survey
- Track 27-2Large-scale surveys of individuals
- Track 27-3Agency for Healthcare research and Quality